Source: MarketScreener

Deltex: Deltex Medical shares soar as TrueVue testing progresses "to plan"

(marketscreener.com) Deltex Medical Group PLC on Monday said testing of its new monitor has so far delivered positive results, and that it plans to reduce the size of its board to help cut costs. The stock was up 18% at 0.18 pence in London on Monday morning. The Chichester, England-based company, which manufactures blood circulation monitoring systems, said that...https://www.marketscreener.com/quote/stock/DELTEX-MEDICAL-GROUP-PLC-4002474/news/Deltex-Medical-shares-soar-as-TrueVue-testing-progresses-to-plan-45493028/?utm_medium=RSS&utm_content=20231204

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
Andy Mears's photo - CEO of Deltex

CEO

Andy Mears

CEO Approval Rating

90/100

Read more